Citations

Clear

367 citation(s) found for "Benson, Al".

Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer
McGarrah, Patrick W. , Novotny, Paul J. , Sargent, Daniel S., Morton, Roscoe F., Fuchs, Charles S. , Benson, Al B. , Findlay, B., Goldberg, Richard M. , Sloan, Jeff A. , McGarrah, Patrick , Branda, Megan E. , Hubbard, Joleen M. , Sargent, Daniel J. , Williamson, Stephen K. , Alberts, Steven R.

Mayo Clinic

Cancer Control | June 20, 2023 | Volume: 30 | Issue: No issue available | Pages: No page available

10.1177/10732748231185047 | PMID 37339926 Get It

Background Previous studies have established that higher baseline quality of life (QOL) scores are associated with improved survival in patients with metastatic colorectal cancer (mCRC). We examined the relationship between overall survival (OS) and baseline QOL. Patients and Methods A total of 1 247 patients with mCRC participating in N9741 (comparing bolus 5-FU/LV, irinotecan [IFL] vs infusional 5-FU/leucovorin [LV]/oxaliplatin [FOLFOX] vs. irinotecan/oxaliplatin [IROX]) provided data at baseline on overall QOL using a single-item linear analogue self-assessment (LASA) 0–100 point scale. The association of OS according to clinically deficient (defined as CD-QOL, score 0–50) vs not clinically deficient (nCD-QOL, score 51–100) baseline QOL scores was tested. A multivariable analysis using Cox proportional hazards modeling was performed to adjust for the effects of multiple baseline factors. An exploratory analysis was performed evaluating OS according to baseline QOL status among patients who did or did not receive second-line therapy. Results Baseline QOL was a strong predictor of OS for the whole cohort (CD-QOL vs nCD-QOL: 11.2 months vs 18.4 months, P < .0001), and in each arm IFL 12.4 vs 15.1 months, FOLFOX 11.1 months vs 20.6 months, and IROX 8.9 months vs 18.1 months. Baseline QOL was associated with baseline performance status (PS) ( P < .0001). After adjusting for PS and treatment arm, baseline QOL was still associated with OS ( P = .017). Conclusions Baseline QOL is an independent prognostic factor for OS in patients with mCRC. The demonstration that patient-assessed QOL and PS are independent prognostic indicators suggests that these assessments provide important complementary prognostic information.
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Azad, Nilofer, Chen, Yi‐Jen , Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Hecht, J. Randolph, Hoffe, Sarah E. , Hunt, Steven R., Johung, Kimberly L. , Joseph, Nora, Kirilcuk, Natalie, Krishnamurthi, Smitha , Maratt, Jennifer K. , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Patel, Hitendra , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Tavakkoli, Anna , Willett, Christopher G. , Algieri, Frankie, Gurski, Lisa A., Stehman, Katie, Meyerhardt, Jeffrey A , Venook, Alan P. , Ciombor, Kristen K. , Cohen, Stacey A. , Hubbard, Joleen M. , Hussan, Hisham , Jeck, William R. , Miller, Eric D. , Parikh, Aparna R. , Patel, Hitendra, Pedersen, Katrina S. , Saltz, Leonard B. , Schneider, Charles John , Williams, Grant R.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | June 12, 2023 | Volume: 21 | Issue: 6 | Pages: 653-677

10.6004/jnccn.2023.0030 | PMID 37308125 Get It

This discussion summarizes the NCCN Clinical Practice Guidelines for managing squamous cell anal carcinoma, which represents the most common histologic form of the disease. A multidisciplinary approach including physicians from gastroenterology, medical oncology, surgical oncology, radiation oncology, and radiology is necessary. Primary treatment of perianal cancer and anal canal cancer are similar and include chemoradiation in most cases. Follow-up clinical evaluations are recommended for all patients with anal carcinoma because additional curative-intent treatment is possible. Biopsy-proven evidence of locally recurrent or persistent disease after primary treatment may require surgical treatment. Systemic therapy is generally recommended for extrapelvic metastatic disease. Recent updates to the NCCN Guidelines for Anal Carcinoma include staging classification updates based on the 9th edition of the AJCC Staging System and updates to the systemic therapy recommendations based on new data that better define optimal treatment of patients with metastatic anal carcinoma.
Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors
Luther, Vera , Barsoumian, Alice E , Konold, Victoria , Balba, Gayle , Benson, Constance A. , Blackburn, Brian G. , Cariello, Paloma F, Perloff, Sarah , Acharya, Kartikey, Bhanot, Nitin , Blyth, Dana M , Casańas, Beata, Chow, Brian , Cutrell, James B , Doshi, Saumil, Finkel, Diana , Graber, Christopher J. , Hazra, Aniruddha , James, Scott H. , Kodiyanplakkal, Rosy Priya , Lee, Mi-Kyung , Marcos, Luis A. , Lora, Alfredo J Mena , Moore, Christopher C. , Nnedu, Obinna, Osorio, Georgina, Reece, Rebecca , Salas, Natalie Mariam , Sanasi-Bhola, Kamla, Schultz, Sara , Serpa, José A., Shnekendorf, Rachel, Wooten, Darcy , Zuckerman, Richard A. , Melia, Michael T. , Chirch, Lisa M , Luther, Vera P , Razonable, Raymund, Azar, Marwan M , Graber, Christopher J , Lee, Mikyung , Vijayan, Tara , Razonable, Raymund R. , Azar, Marwan M. , Butt, Saira , Cleveland, Kerry O. , Hochberg, Natasha S. , Kaltsas, Anna , Paras, Molly L , Weisenberg, Scott A.

Mayo Clinic

Open Forum Infectious Diseases | May 27, 2023 | Volume: 10 | Issue: 6 | Pages: No page available

10.1093/ofid/ofad289 | PMID 37397270 Get It

Abstract The Infectious Diseases Society of America (IDSA) has set clear priorities in recent years to promote inclusion, diversity, access, and equity (IDA&E) in infectious disease (ID) clinical practice, medical education, and research. The IDSA IDA&E Task Force was launched in 2018 to ensure implementation of these principles. The IDSA Training Program Directors Committee met in 2021 and discussed IDA&E best practices as they pertain to the education of ID fellows. Committee members sought to develop specific goals and strategies related to recruitment, clinical training, didactics, and faculty development. This article represents a presentation of ideas brought forth at the meeting in those spheres and is meant to serve as a reference document for ID training program directors seeking guidance in this area.
Survival outcomes following autologous stem cell transplant with melphalan 140mg/m 2 versus 200mg/m 2 preparative regimens in patients with multiple myelo
Sharma, Nidhi , Benson, Evan, Zhao, Qiuhong , Elder, Patrick , Rosko, Ashley , Bumma, Naresh , Khan, Abdullah , Umyarova, Elvira , Efebera, Yvonne A. , Benson, Don M. , Nunnelee, Jordan , Cottini, Francesca , Devarakonda, Srinivas

Mayo Clinic

Leukemia & Lymphoma | May 18, 2023 | Volume: 64 | Issue: 7 | Pages: 1315-1321

10.1080/10428194.2023.2213366 | PMID 37199099 Get It

Development and modification of a dysphagia question prompt list to improve patient‐physician communication: Incorporating both esophageal expert and patient perspectives
Achalu, Sudharshan, Berry, Rani , Zhuo, Justin , Bredenoord, Albert J. , Clarke, John O. , Fass, Ronnie , Gyawali, C. Prakash , Kahrilas, Peter J. , Katzka, David A. , Massey, Benson T. , Savarino, Edoardo , Vela, Marcelo F. , Kamal, A. N. , Penagini, Roberto , Roman, S , Savarino, Edoardo , Vela, Marcelo F , Kamal, Afrin N , Clarke, J , Gyawali, C P , Fass, Ronnie , Penagini, Roberto , Roman, Sabine

Mayo Clinic

Neurogastroenterology & Motility | May 1, 2023 | Volume: 35 | Issue: 8 | Pages: No page available

10.1111/nmo.14600 | PMID 37122123 Get It

AbstractBackgroundQuestion prompt lists (QPLs) are structured sets of disease‐specific questions, intended to encourage question‐asking by patients and enhance patient‐physician communication. To date, a dysphagia‐specific QPL has not been developed for patients with esophageal dysphagia symptoms. We aim to develop a dysphagia‐specific QPL incorporating both esophageal expert and patient perspectives, applying rigorous methodology.MethodsThe QPL content was generated applying a two‐round modified Delphi (RAND/UCLA) method among 11 experts. In round one, experts provided five answers to the prompts: “What general questions should patients ask when being seen for dysphagia?” and “What questions do I not hear patients asking but, given my experience, I believe they should be asking?” In round two, experts rated proposed questions on a 5‐point Likert scale. Responses rated as “essential” or “important”, determined by an a priori median threshold of ≥4.0, were accepted for inclusion. Subsequently, 20 patients from Stanford Health Care were enrolled to modify the preliminary QPL, to incorporate their perspectives and opinions. Patients independently rated questions applying the same 5‐point Likert scale. At the end, patients were encouraged to propose additional questions to incorporate into the QPL by open‐endedly asking “Are there questions we didn't ask, that you think we should?”Key ResultsEleven experts participated in both voting rounds. Of 85 questions generated from round one, 60 (70.6%) were accepted for inclusion, meeting a median value of ≥4.0. Questions were combined to reduce redundancy, narrowing down to 44 questions. Questions were categorized into the following six themes: 1. “What is causing my dysphagia?”; 2. “Associated symptoms”; 3. “Testing for dysphagia”; 4. “Lifestyle modifications”; 5. “Treatment for dysphagia”; and 6. “Prognosis”. The largest number of questions covered “What is causing my dysphagia” (27.3%). Twenty patients participated and modified the QPL. Of the 44 questions experts agreed were important, only 30 questions (68.2%) were accepted for inclusion. Six patients proposed 10 additional questions and after incorporating the suggested questions, the final dysphagia‐specific QPL created by esophageal experts and modified by patients consisted of 40 questions.Conclusions & InferencesIncorporating expert and patient perspectives, we developed a dysphagia‐specific QPL to enhance patient‐physician communication. Our study highlights importance of incorporating patient perspective when developing such a communication tool. Further studies will measure the impact of this communication tool on patient engagement.
Real-world effectiveness of switching treatment after initial platform injectable disease-modifying therapies in pediatric multiple sclerosis in the US (P14-3.008)
Abrams, Aaron , Waltz, Michael , Casper, T. Charles , Aaen, Gregory , Francisco, Carla , Gorman, Mark , Graves, Jennifer, Lotze, Timothy , Mar, Soe , Rose, John , Schreiner, Teri , Tillema, Jan‐Mendelt , Wheeler, Yolanda , Benson, Leslie , Charvet, Leigh , Chitnis, Tanuja , Goyal, Manu S. , Krupp, Lauren , Rensel, Mary R. , Rodriguez, Moses , Rutatangwa, Alice , Schreiner, Teri , Shukla, Nikita , Weinstock‐Guttman, Bianca , Waubant, Emmanuelle L. , Krysko, Kristen M.

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000203650 Get It

Longitudinal Cognitive Screening Findings in Pediatric MS vs. Pediatric Controls and Adult MS in a Multi-center Cohort (S31.008)
O’Neill, Kimberly, Waltz, Michael , Casper, T. Charles , George, Allan , Gorman, Mark , Mar, Soe , Ness, Jayne , Schreiner, Teri , Wheeler, Yolanda , Aaen, Gregory , Abrams, Aaron , Lotze, Timothy , Rose, John , Tillema, Jan‐Mendelt , O'Neill, Kimberly , Charvet, Leigh , Benson, Leslie, Goyal, Manu S. , Schreiner, Teri , Waubant, Emmanuelle L. , Weinstock‐Guttman, Bianca , Chitnis, Tanuja , Rensel, Mary R. , Rodriguez, Moses , Shukla, Nikita , Krupp, Lauren

Mayo Clinic

Neurology | April 28, 2023 | Volume: 100 | Issue: 17_supplement_2 | Pages: No page available

10.1212/wnl.0000000000201998 Get It

Incremental diagnostic yield and clinical outcomes of lateral decubitus CT myelogram immediately following negative lateral decubitus digital subtraction myelogram
Mark, Ian T. , Kim, Dong Kun , Benson, John C. , Madhavan, Ajay A. , Morris, Pearse , Verdoorn, Jared T. , Shlapak, Darya P. , Mark, Ian , Benson, John , Diehn, Felix E. , Madhavan, Ajay A , Morris, Pearse P, Oien, Michael P , Verdoorn, Jared T , Kissoon, Narayan , Liebo, Greta B. , Morris, Jonathan M. , Carr, Carrie M.

Mayo Clinic

The Neuroradiology Journal | April 27, 2023 | Volume: 36 | Issue: 5 | Pages: 593-600

10.1177/19714009231173110 | PMID 37128777 Get It

Introduction Spontaneous intracranial hypotension (SIH) caused by a spinal cerebrospinal fluid (CSF) leak classically presents with orthostatic headache. Digital subtraction myelography (DSM) has a well-established diagnostic yield in the absence of extradural spinal collection. At our institution, DSM is followed by lateral decubitus CT myelogram (LDCTM) in the same decubitus position to increase diagnostic yield of the combined study. We evaluated the incremental diagnostic yield of LDCTM following negative DSM and reviewed patient outcomes. Methods Retrospective review of consecutive DSMs with subsequent LDCTM from April 2019 to March 2021 was performed. Combined reports were reviewed, and studies with positive DSMs were excluded. Of the exams with negative DSM, only studies with LDCTM reports identifying potential leak site were included. Interventions and follow-up clinical notes were reviewed to assess symptoms improvement following treatment. Results Of the 83 patients with negative DSMs, 11 (13.2%) had positive leak findings on LDCTMs, and 21 (25.3%) were equivocal. Of 11 positive LDCTMs, 6 leaks were nerve sheath tears (NSTs) and 5 were CSF-venous fistulas (CVFs). 10/11 (90.9%) had intervention and follow-up, with 9/10 (90%) having positive clinical outcome. Of the 21 equivocal LDCTM patients (19 CVFs and 2 NSTs), 15 (71.4%) had interventions and follow-up, with 3/15 (20.0%) with positive clinical outcomes. Conclusion LDCTM following negative DSM has an incremental diagnostic yield up to 38.6%, with up to 14.5% of positive patient outcomes following treatment. LDCTM should be considered after DSM to maximize diagnostic yield of the combined exam.
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2
Schreiner, Teri , Wilson-Murphy, Molly , Mendelt-Tillema, Jan, Waltz, Michael , Codden, Rachel , Gorman, Mark , Krupp, Lauren , Lotze, Tim, Mar, Soe , Ness, Jayne , Roalstad, Shelly, Rose, John , Shukla, Nikita , Wheeler, Yolanda , Casper, T. Charles , Krupp, Lauren , Rensel, Mary R. , Chitnis, Tanuja , Schreiner, Teri , Shukla, Nikita Malani , Benson, Leslie, Goyal, Manu S. , Rodriguez, Moses , Waubant, Emmanuelle L.

Mayo Clinic

Multiple Sclerosis Journal | March 24, 2023 | Volume: 29 | Issue: 4-5 | Pages: 576-584

10.1177/13524585231151948 | PMID 36960480 Get It

Background: Pediatric patients with multiple sclerosis (POMS) and related disorders, clinically isolated syndrome (CIS), myelin oligodendrocyte glycoprotein antibody disorder (MOGAD), and neuromyelitis optica spectrum disorder (NMOSD), are commonly treated with immunosuppressants. Understanding the impact of SARS-CoV-2 infection in patients may inform treatment decisions. Objective: Characterize SARS-CoV-2 infection prevalence and severity among a cohort of patients with POMS and related disorders, as well as the impact of disease-modifying therapies (DMTs). Methods: POMS and related disorders patients enrolled in a large, prospective registry were screened for COVID-19 during standard-of-care neurology visits. If confirmed positive of having infection, further analysis was undertaken. Results: Six hundred and sixty-nine patients were surveyed between March 2020 and August 2021. There were 73 confirmed COVID-19 infections. Eight of nine hospitalized patients (89%), and all patients admitted to the ICU were treated with B cell depleting therapy. The unadjusted odds ratio of hospitalization among those who tested positive of having had COVID-19 was 15.27 among those on B-cell-depleting therapy ( p = 0.016). Conclusions: B-cell-depleting treatment was associated with a higher risk of COVID-19, higher rates of hospitalization, and ICU admission, suggesting this therapy carries a higher risk of severe infection in POMS and related disorders.
Safety profile and technical success rate of computed tomography–guided atlanto-axial lateral articulation injections
Liou, Harris , Murthy, Naveen S. , Carr, Carrie M. , Madhavan, Ajay A. , Kim, Dong Kun , Diehn, Felix E. , Lehman, Vance T. , Carr, Carrie M , Madhavan, Ajay A , Benson, John C. , Oien, Michael P

Mayo Clinic

Pain Medicine | February 28, 2023 | Volume: 24 | Issue: 7 | Pages: 782-786

10.1093/pm/pnad029 | PMID 36852864 Get It

Abstract Objective To describe the technique, safety profile, and outcome of computed tomography (CT)–guided atlanto-axial lateral articulation injections performed at our institution. Methods Consecutive cases of all CT-guided atlanto-axial injections performed from January 2017 to April 2022 at our institution were searched in the electronic medical records. Patient charts were reviewed for demographics, characterization of pain, potential altered anatomy, pain level before and immediately after the procedure, procedure technique, complications, and follow-up outcomes, if available. Results Forty-five injections in 40 different patients were included. The average age was 67.4 years, and 28 (70%) of the patients were female. Of the 45 injections, 43 (96%) were technically successful. The average change in pain score (0–10) from immediately before to immediately after the injection was –3.36 (SD = 2.87, range = –8 to +3). Of all injections, 14 (31%) had a postprocedural pain score of zero. In 2 cases (4%), patients reported an increase in pain score immediately after the injection. In 3 cases (7%), transient non–vertebral artery vascular uptake of contrast was documented during the procedure, which could be cleared with needle repositioning. There were no complications. Conclusion CT-guided atlanto-axial lateral articulation injection is a safe procedure with a high technical success rate. It allows for direct visualization of vital structures and provides an alternative option to the traditional fluoroscopic guidance, especially in cases of prior technically unsuccessful fluoroscopically guided injection or altered anatomy.